Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 · New England Journal of Medicine · 2,482 citations
https://doi.org/10.1056/nejmoa2025845
R
Rajiv Agarwal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
578
Papers
18.2K
Citations
67
h-index
194
i10-index
Rajiv Agarwal is an academic researcher from University of Indianapolis. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Dialysis and Renal Disease Management & Hormonal Regulation and Hypertension. The author has an h-index of 67, co-authored 492 publications.
ORCID: 0000-0002-3146-7231Papers by this author
worksAssessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model
2023 · Research Square · 579 citations
https://doi.org/10.21203/rs.3.rs-2566942/v1
Molecular mechanisms and therapeutic targets for diabetic kidney disease
2022 · Kidney International · 575 citations
https://doi.org/10.1016/j.kint.2022.05.012
Out-of-Hemodialysis-Unit Blood Pressure Is a Superior Determinant of Left Ventricular Hypertrophy
2005 · Hypertension · 178 citations
https://doi.org/10.1161/01.hyp.0000196279.29758.f4
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)
2022 · Nephrology Dialysis Transplantation · 152 citations
https://doi.org/10.1093/ndt/gfac198
Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective
2020 · Journal of Natural Products · 101 citations
https://doi.org/10.1021/acs.jnatprod.9b00949
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat